Citra Health Solutions Acquires SironaHealth
Purchase Broadens Healthcare Company’s Value-Based Care Management, Population Health & Technology Suite
SironaHealth, a URAC and NCQA accredited health services company, has a long history of clinical care coordination and patient care and case management. With a multi-modality approach, the clinical teams are driving quality care into programs that support patients’ access and outcomes. SironaHealth will do business as a Citra Health Solutions company and will continue to maintain an operational center in Portland, Maine.
“By managing the health of populations, including disease management, care management and wellness, Sirona will fit into Citra’s holistic approach to drive increased member engagement, reduce health care costs and improve the quality of care,” said Howard Buff, CEO and Founder of Citra Health Solutions. “The integrated healthcare model will provide a service and technology enabled platform that supports a multitude of payment models and risk arrangements for Providers and Health Systems.”
Citra helps healthcare organizations maximize performance and empower consumers. Best-in-class solutions include 24/7 care coordination, point of need engagement, re-admission reduction, ER diversion, star rating improvement, bundled payment administration and chronic care management. Serving over 22 million members across a nationwide service and technology foundation, Citra continues its quest to improve every organizations’
With CMS designing and releasing new, specialized programs to address chronic illnesses, Citra-led programs are already assisting more 2500 providers and over 250,000 patients to engage in advanced care paradigms that are proving beneficial across the United States with patients successfully co-managing a multitude of conditions. As oncology and joint replacement programs come on-line this year, Citra is already leading global healthcare mind share with proprietary technology and processes that assist in delivering successful clinical outcomes. Citra’s acquisition of SironaHealth further increases its clinical capabilities to meet the needs of the market and strengthens the portfolio of solutions to meet the needs of all healthcare’s personas: Patient, Provider and Payer.
“We view ourselves as innovators in the healthcare marketplace, so we know our company will be the perfect complement to Citra,” said Jeff Forbes, CEO of SironaHealth. “Our mission has been to guarantee satisfaction through compassionate and competent care with a relentless focus on quality improvement and that will not change. What will change is the fact that with these augmented resources, we will have the ability to offer our customers more than ever before.”
Citra Health Solutions is a leading healthcare services and technology firm that solves for the needs of providers, hospital systems and payers in the transition to value-based care. In this new era of payment and delivery, Citra empowers clients with proven technology, population health, analytics and care management services to strategically expand market opportunity, diversify revenue streams and reduce the cost of care. To learn more, visit www.citrahealth.com.
SironaHealth is a healthcare services company that helps health insurers, hospitals, providers, and other healthcare focused organizations engage patients with personalized care and the resources to connect them to the appropriate resources and care settings. By using the latest technology advancements, the patient is given various streams of connectivity to manage and maintain their health to reach the optimal outcomes. To learn more, visit www.sironahealth.com.
About Great Point Partners
Great Point Partners (“GPP”) is a leading health care investment firm with approximately $900 million of equity capital under management investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP II, which closed on $215 million in 2013. Great Point manages both private and public equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 health care companies and the private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical infrastructure, devices and diagnostics, health care services, outsourcing, and information technology.